PWMG
MRNA icon

Provence Wealth Management Group’s Moderna MRNA Stock Holding History

Provence Wealth Management Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$5.57K Hold
56
– – ﹤0.01% 349
2023
Q3 		$5.78K Buy
+56
New +$6.25K ﹤0.01% 340

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Provence Wealth Management Group's MRNA Position: Q4 2023 in Review

Provence Wealth Management Group held its Moderna (MRNA) position steady in Q4 2023 at 56 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

Provence Wealth Management Group first reported a position in MRNA in Q3 2023 and has held it in 2 quarters since. The position peaked at $5.78K in Q3 2023. 885 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Provence Wealth Management Group held 56 shares of Moderna worth $5.57K as of Q4 2023.
  • Provence Wealth Management Group left its Moderna share count unchanged in Q4 2023.
  • Moderna made up ﹤0.01% of Provence Wealth Management Group's portfolio in Q4 2023, its #349 holding.
  • Provence Wealth Management Group first reported a position in Moderna in Q3 2023 and has held it in 2 quarters since.
  • Provence Wealth Management Group's Moderna position peaked at $5.78K in Q3 2023.
  • 885 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.